Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Breast 47Genitourinary 18Gastrointestinal 12Gynecologic 10Other hematologic neoplasm 7Head & Neck 6Thoracic 4Sarcoma 4Lymphoid 4Myeloid 3Endocrine 3Dermatologic 2CNS 2Tumor-Agnostic 1Plasma cell 1Other solid neoplasm 1Other neoplasm 1Other 1

Conditions

Soft Tissue Neoplasms 1Sarcoma, Endometrial Stromal 1Sarcoma 1Neurofibrosarcoma 1Neurofibromatosis 1 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Hypersensitivity 1Gastrointestinal Stromal Tumors 1Adrenocortical Adenoma 1

Interventions

Radiotherapy 221Cyclophosphamide 211Doxorubicin 210Temozolomide 182Ifosfamide 121Filgrastim 111Imatinib Mesylate 104Etoposide 101Vincristine 92Gemcitabine 89Bevacizumab 83Magnetic Resonance Spectroscopy 81Irinotecan 79pembrolizumab 75Radiation 70Carboplatin 65Methotrexate 62pazopanib 61Nivolumab 58Cisplatin 58fludarabine phosphate 57Surgical Procedures, Operative 57Peripheral Blood Stem Cell Transplantation 57Specimen Handling 56Trabectedin 52Docetaxel 50Biopsy 50Busulfan 49Melphalan 46Paclitaxel 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
High-Energy Shock Waves × Sarcoma × Clear all
NCT02700230 2024-09-27

Vaccine Therapy in Treating Patients with Malignant Peripheral Nerve Sheath Tumor That is Recurrent or Cannot Be Removed by Surgery

Mayo Clinic

Phase 1 Completed
9 enrolled
CNSSarcoma

Neurofibromatosis 1, Neurofibrosarcoma

NCT02734823 2024-03-18

Long Term Effects of Tyrosine Kinase Inhibitor Therapy on Ovarian Reserve and Fertility in Patients With Chronic Myeloid Leukemia or Gastrointestinal Stromal Tumor

University of Southern California

Withdrawn
GastrointestinalMyeloidOther hematologic neoplasmSarcoma

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Gastrointestinal Stromal Tumors

NCT02150213 2016-12-05

Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492

Novartis

Phase 2 Completed
59 enrolled 6 charts
EndocrineGynecologicSarcoma

Sarcoma, Endometrial Stromal, Adrenocortical Adenoma

NCT02834585 2016-07-15

MUSTT

University of Genova

Unknown
70 enrolled
Sarcoma

Hypersensitivity, Sarcoma, Soft Tissue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡